WIP1, a Homeostatic Regulator of the DNA Damage Response, Is Targeted by HIPK2 for Phosphorylation and Degradation

Molecular Cell

Volumn 51, Issue 3, 2013, Pages 374-385

  Choi, DongWook ^a   Na, Wooju ^a   Kabir, MohammadHumayun ^b   Yi, Eunbi ^c   Kwon, Seonjeong ^d   Yeom, Jeonghun ^b,e   Ahn, Jang Won ^a   Choi, Hee Hyun ^f   Lee, Youngha ^a   Seo, KyoungWan ^a   Shin, MinKyoo ^a   Park, Se Ho ^c   Yoo, HaeYong ^a   Isono, Kyo ichi ^g   Koseki, Haruhiko ^g   Kim, Seong Tae ^f   Lee, Cheolju ^b,e   Kwon, YunheeKim ^d   Choi, CheolYong ^a  

^a Sungkyunkwan University   (South Korea)

^b Korea Institute of Science and Technology   (South Korea)

^c Korea University   (South Korea)

^d Kyung Hee University   (South Korea)

^e University of Science and Technology (UST)   (South Korea)

^f Sungkyunkwan University School of Medicine   (South Korea)

^g RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; HISTONE H2AX; HISTONE H2AX GAMMA; HOMEODOMAIN INTERACTING PROTEIN KINASE 2; PHOSPHATASE; UNCLASSIFIED DRUG; WILD TYPE P53 INDUCED PHOSPHATASE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CYCLE CHECKPOINT; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; ENZYME STABILITY; HUMAN; HUMAN CELL; IONIZING RADIATION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; RADIATION RESPONSE; SIGNAL TRANSDUCTION; SURVIVAL RATE;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CARRIER PROTEINS; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; DNA DAMAGE; DNA REPAIR; HEK293 CELLS; HELA CELLS; HISTONES; HUMANS; MICE; MICE, TRANSGENIC; PHOSPHOPROTEIN PHOSPHATASES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RADIATION, IONIZING; SIGNAL TRANSDUCTION; UBIQUITINATION;

ATAXIA TELANGIECTASIA; MUS;

EID: 84881558218     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2013.06.010     Document Type: Article

References (33)

1. Bulavin D.V., Phillips C., Nannenga B., Timofeev O., Donehower L.A., Anderson C.W., Appella E., Fornace A.J. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf) pathway. Nat. Genet. 2004, 36:343-350.
2. Calzado M.A., Renner F., Roscic A., Schmitz M.L. HIPK2: a versatile switchboard regulating the transcription machinery and cell death. Cell Cycle 2007, 6:139-143.
3. Choi D.W., Seo Y.M., Kim E.A., Sung K.S., Ahn J.W., Park S.J., Lee S.R., Choi C.Y. Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1. J.Biol. Chem. 2008, 283:4682-4689.
4. D'Orazi G., Sciulli M.G., Di Stefano V., Riccioni S., Frattini M., Falcioni R., Bertario L., Sacchi A., Patrignani P. Homeodomain-interacting protein kinase-2 restrains cytosolic phospholipase A2-dependent prostaglandin E2 generation in human colorectal cancer cells. Clin. Cancer Res. 2006, 12:735-741.
5. D'Orazi G., Rinaldo C., Soddu S. Updates on HIPK2: a resourceful oncosuppressor for clearing cancer. J.Exp. Clin. Cancer Res. 2012, 31:63.
6. Dauth I., Krüger J., Hofmann T.G. Homeodomain-interacting protein kinase 2 is the ionizing radiation-activated p53 serine 46 kinase and is regulated by ATM. Cancer Res. 2007, 67:2274-2279.
7. Ditch S., Paull T.T. The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem. Sci. 2012, 37:15-22.
8. Fiscella M., Zhang H., Fan S., Sakaguchi K., Shen S., Mercer W.E., Vande Woude G.F., O'Connor P.M., Appella E. Wip1, a novel human protein phosphatase that is induced in response to ionizing radiation in a p53-dependent manner. Proc. Natl. Acad. Sci. USA 1997, 94:6048-6053.
9. Fuku T., Semba S., Yutori H., Yokozaki H. Increased wild-type p53-induced phosphatase 1 (Wip1 or PPM1D) expression correlated with downregulation of checkpoint kinase 2 in human gastric carcinoma. Pathol. Int. 2007, 57:566-571.
10. Isono K., Nemoto K., Li Y., Takada Y., Suzuki R., Katsuki M., Nakagawara A., Koseki H. Overlapping roles for homeodomain-interacting protein kinases hipk1 and hipk2 in the mediation of cell growth in response to morphogenetic and genotoxic signals. Mol. Cell. Biol. 2006, 26:2758-2771.
11. Kabir M.H., Suh E.J., Lee C. Comparative phosphoproteome analysis reveals more ERK activation in MDA-MB-231 than in MCF-7. Int. J. Mass Spectrom. 2012, 309:1-12.
12. Kim Y.H., Choi C.Y., Lee S.J., Conti M.A., Kim Y. Homeodomain-interacting protein kinases, a novel family of co-repressors for homeodomain transcription factors. J.Biol. Chem. 1998, 273:25875-25879.
13. Kim S.Y., Choi D.W., Kim E.A., Choi C.Y. Stabilization of HIPK2 by escape from proteasomal degradation mediated by the E3 ubiquitin ligase Siah1. Cancer Lett. 2009, 279:177-184.
14. Lavin M.F., Kozlov S. ATM activation and DNA damage response. Cell Cycle 2007, 6:931-942.
15. Lavra L., Rinaldo C., Ulivieri A., Luciani E., Fidanza P., Giacomelli L., Bellotti C., Ricci A., Trovato M., Soddu S., et al. The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas. PLoS ONE 2011, 6:e20665.
16. Lowe J., Cha H., Lee M.O., Mazur S.J., Appella E., Fornace A.J. Regulation of the Wip1 phosphatase and its effects on the stress response. Front. Biosci. 2012, 17:1480-1498.
17. Lu X., Nguyen T.A., Moon S.H., Darlington Y., Sommer M., Donehower L.A. The type 2C phosphatase Wip1: an oncogenic regulator of tumor suppressor and DNA damage response pathways. Cancer Metastasis Rev. 2008, 27:123-135.
18. Mao J.H., Wu D., Kim I.J., Kang H.C., Wei G., Climent J., Kumar A., Pelorosso F.G., DelRosario R., Huang E.J., Balmain A. Hipk2 cooperates with p53 to suppress γ-ray radiation-induced mouse thymic lymphoma. Oncogene 2012, 31:1176-1180.
19. Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007, 316:1160-1166.
20. Mihaylova M.M., Shaw R.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 2011, 13:1016-1023.
21. Pierantoni G.M., Rinaldo C., Mottolese M., Di Benedetto A., Esposito F., Soddu S., Fusco A. High-mobility group A1 inhibits p53 by cytoplasmic relocalization of its proapoptotic activator HIPK2. J.Clin. Invest. 2007, 117:693-702.
22. Rinaldo C., Prodosmo A., Siepi F., Soddu S. HIPK2: a multitalented partner for transcription factors in DNA damage response and development. Biochem. Cell Biol. 2007, 85:411-418.
23. Rossi M., Demidov O.N., Anderson C.W., Appella E., Mazur S.J. Induction of PPM1D following DNA-damaging treatments through a conserved p53 response element coincides with a shift in the use of transcription initiation sites. Nucleic Acids Res. 2008, 36:7168-7180.
24. Sanli T., Rashid A., Liu C., Harding S., Bristow R.G., Cutz J.C., Singh G., Wright J., Tsakiridis T. Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int. J. Radiat. Oncol. Biol. Phys. 2010, 78:221-229.
25. Shreeram S., Demidov O.N., Hee W.K., Yamaguchi H., Onishi N., Kek C., Timofeev O.N., Dudgeon C., Fornace A.J., Anderson C.W., et al. Wip1 phosphatase modulates ATM-dependent signaling pathways. Mol. Cell 2006, 23:757-764.
26. Shreeram S., Hee W.K., Demidov O.N., Kek C., Yamaguchi H., Fornace A.J., Anderson C.W., Appella E., Bulavin D.V. Regulation of ATM/p53-dependent suppression of myc-induced lymphomas by Wip1 phosphatase. J.Exp. Med. 2006, 203:2793-2799.
27. Sombroek D., Hofmann T.G. How cells switch HIPK2 on and off. Cell Death Differ. 2009, 16:187-194.
28. Viollet B., Horman S., Leclerc J., Lantier L., Foretz M., Billaud M., Giri S., Andreelli F. AMPK inhibition in health and disease. Crit. Rev. Biochem. Mol. Biol. 2010, 45:276-295.
29. Wei G., Ku S., Ma G.K., Saito S., Tang A.A., Zhang J., Mao J.H., Appella E., Balmain A., Huang E.J. HIPK2 represses beta-catenin-mediated transcription, epidermal stem cell expansion, and skin tumorigenesis. Proc. Natl. Acad. Sci. USA 2007, 104:13040-13045.
30. Winter M., Sombroek D., Dauth I., Moehlenbrink J., Scheuermann K., Crone J., Hofmann T.G. Control of HIPK2 stability by ubiquitin ligase Siah-1 and checkpoint kinases ATM and ATR. Nat. Cell Biol. 2008, 10:812-824.
31. Xu B., Kim S.T., Lim D.S., Kastan M.B. Two molecularly distinct G(2)/M checkpoints are induced by ionizing irradiation. Mol. Cell. Biol. 2002, 22:1049-1059.
32. Zannella V.E., Cojocari D., Hilgendorf S., Vellanki R.N., Chung S., Wouters B.G., Koritzinsky M. AMPK regulates metabolism and survival in response to ionizing radiation. Radiother. Oncol. 2011, 99:293-299.
33. Zhang X., Wan G., Mlotshwa S., Vance V., Berger F.G., Chen H., Lu X. Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway. Cancer Res. 2010, 70:7176-7186.